| A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease (NCT05348915) | Pfizer | 2022-03-29 |
| A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises (NCT04927247) | Pfizer | 2021-12-09 |
| A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises (NCT04935879) | Pfizer | 2021-10-04 |
| Evaluation of Virtual Reality to Save Morphinic in the Treatment of Vaso-occlusive Seizures of Sickle Cell Patients Consulting in the Emergency Room (NCT04756375) | Assistance Publique - Hôpitaux de Paris | 2021-03-04 |
| Intranasal Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the PED (NCT04150757) | Abigail Nixon | 2019-12-19 |
| Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia (NCT04301336) | Beni-Suef University | 2019-11-01 |
| Music Therapy in Sickle Cell Disease Vaso-occlusive Crisis (NCT03639805) | Assistance Publique - Hôpitaux de Paris | 2018-09-28 |
| Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease (NCT03353584) | St. Jude Children's Research Hospital | 2018-02-05 |
| Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis (NCT03296345) | UCSF Benioff Children's Hospital Oakland | 2016-06-01 |
| Validation of a Predictive Score of Acute Chest Syndrome (NCT03032055) | Soutien aux Actions contre les Maladies du Globule Rouge | 2016-01-01 |
| Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease (NCT02433158) | GlycoMimetics Incorporated | 2015-12-16 |
| Apixaban in Patients With Sickle Cell Disease (NCT02179177) | Nirmish Shah | 2015-01-01 |
| Nitrous Oxide Analgesia Vaso-occlusive Crisis (NCT01891812) | Columbia University | 2013-11-12 |
| Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC) (NCT01737814) | Mast Therapeutics, Inc. | 2013-05-01 |
| A Study of Varespladib Infusion in Subjects With Sickle Cell Disease. (NCT01522196) | Anthera Pharmaceuticals | 2012-02-01 |
| Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease (NCT01501643) | Assistance Publique - Hôpitaux de Paris | 2011-11-01 |
| Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo (NCT01419977) | Duke University | 2011-05-01 |
| Comparison of Patient Controlled Analgesia (PCA) Versus Bolus Narcotic Therapy for the Treatment of Vaso-Occlusive Crisis (VOC) (NCT00711698) | Johns Hopkins University | 2007-09-01 |
| IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome (NCT00434473) | Anthera Pharmaceuticals | 2006-12-01 |
| Steroid Treatment for Sickle Cell Pain Crisis (NCT00263562) | Baylor College of Medicine | 2005-12-01 |